Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
A new observational study raises the possibility that calcium-channel blockers (CCBs) may be associated with a higher risk for breast cancer. Although previous studies examining this relationship have failed to turn up convincing evidence of a link, the authors of a paper published in JAMA Internal Medicine state that their study is the first to look at long-term use of CCBs in a contemporary population.`
Hey, check out all the research scientist jobs. Post your resume today!
